Fam Beshoy Nabil, El-Sayed Ghada Gamal El-Din, Reyad Raafat Mahfouz, Mansour Ikramy
Department of Anesthesiology and Pain Management, Nasser Institute for Research and Treatment, Cairo, Egypt.
Department of Anesthesia and Pain Management, National Cancer Institute, Cairo University, Cairo, Egypt.
Saudi J Anaesth. 2018 Apr-Jun;12(2):227-234. doi: 10.4103/sja.SJA_576_17.
Breast cancer is a common neoplastic tumor in women, and the postmastectomy pain syndrome has been reported frequently after surgical treatment. The injury of the intercostobrachial nerve is considered the major cause of this type of pain.
Evaluation of efficacy and safety of pulsed radiofrequency (PRF) and steroid injection on the 2 and 3 thoracic (T2 and T3) dorsal root ganglions (DRGs) for intercostobrachial neuralgia (ICBN) postmastectomy.
This study was conducted on 100 patients with ICBN postmastectomy. The PRF waves were applied for 120 s twice on T2 and T3 DRGs then 1 ml of 4 mg dexamethasone and 1 ml of bupivacaine 0.25% were injected at each level then the technique was repeated three times 1 week apart for each patient.
After 6 months from the latest intervention, the mean of visual analog scale dropped from 7.48 to 4.7 ( = 0.005712) and the mean of the quality of life scale improved to 6.88 after being 4.66 ( < 0.00001) before the intervention and 64.68% of the patients decided that they would certainly repeat the procedure if they could go back in time and 66.64% would certainly recommend the same procedure to a family member. The analgesics consumption decreased mainly in the 1 month but increased again after 6 months (not significant). No serious complications were recorded.
PRF and steroid injection on T2 and T3 DRGs assumed an effective and safe method for ICBN postmastectomy treatment.
乳腺癌是女性常见的肿瘤性疾病,手术治疗后乳房切除术后疼痛综合征屡有报道。肋间臂神经损伤被认为是这类疼痛的主要原因。
评估脉冲射频(PRF)联合类固醇注射对2、3胸段(T2和T3)背根神经节(DRG)治疗乳房切除术后肋间臂神经痛(ICBN)的疗效和安全性。
本研究纳入100例乳房切除术后ICBN患者。对T2和T3 DRG施加PRF波120秒,重复两次,然后在每个节段注射1毫升4毫克地塞米松和1毫升0.25%布比卡因,随后对每位患者每隔1周重复该技术3次。
在最后一次干预6个月后,视觉模拟量表平均分从7.48降至4.7(P = 0.005712),生活质量量表平均分从干预前的4.66提高到6.88(P < 0.00001),64.68%的患者表示如果能时光倒流肯定会再次接受该治疗,66.64%的患者肯定会向家人推荐相同治疗。镇痛药消耗量主要在1个月时减少,但6个月后再次增加(无统计学意义)。未记录到严重并发症。
对T2和T3 DRG进行PRF联合类固醇注射是乳房切除术后ICBN治疗的一种有效且安全的方法。